FAST NEWS: InnoCare Pharma’s Loss Soars on R&D Costs, Exchange Losses
The latest: InnoCare Pharma Ltd. (9969.HK) said it expects to report its net loss soared about 13 times to 910 million yuan ($134 million) last year, according to a profit…
RELATED ARTICLES
-
Akeso marks profit milestone with swift rights issue
9926.HK -
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
1672.HK
-
Profit setback for Simcere Pharma in novel drugs quest
2096.HK
- Jiuyuan Gene seeks IPO cash for bet on weight-loss drugs
